Microalbuminuria Is Associated With Left Ventricular Systolic Function in Newly Diagnosed Hypertensive Patients

Selim Aydemir1, Sidar Şiyar Aydın2, Onur Altınkaya1

  • 1Department of Cardiology, University of Health Sciences, Erzurum City Hospital, Erzurum, Turkey.

Insights

Hypertension treatment improved cardiac function, with decreased urinary albumin creatinine ratio (UACR) linked to better left ventricular global longitudinal strain (LVGLS). UACR can monitor treatment effectiveness in hypertensive patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Hypertension Research

Background:

  • Hypertension (HT) is a major global cardiovascular (CV) risk factor, often leading to cardiac dysfunction.
  • Urinary albumin creatinine ratio (UACR) indicates microalbuminuria and predicts adverse CV events in HT patients.

Purpose of the Study:

  • To investigate the relationship between UACR and cardiac function in newly diagnosed HT patients.
  • To assess if UACR changes correlate with cardiac function improvements after treatment.

Main Methods:

  • Prospective study of 104 newly diagnosed HT patients treated with ACEIs.
  • Collected urine samples, 24-h BP monitoring, echocardiography (TTE), and LVGLS via speckle-tracking before and after 3 months of treatment.
  • Linear regression analyzed UACR and cardiac parameter relationships.

Main Results:

  • Treatment reduced blood pressure and UACR significantly.
  • Decreased UACR showed a significant association with improved LVGLS.
  • Microalbuminuria reduction correlated independently with LVGLS improvement.

Conclusions:

  • A significant link exists between microalbuminuria (UACR) and LVGLS.
  • Blood pressure control and UACR reduction in HT patients improve cardiac function.
  • UACR is a potentially valuable marker for monitoring LV systolic function improvement.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
754
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
348
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
749
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.6K